ARTICLE | Distillery Therapeutics
Therapeutics: NADPH oxidase 2 (NOX2)
September 29, 2016 7:00 AM UTC
Mouse studies suggest inhibiting NOX2 could help treat post-influenza pneumonia caused by methicillin-resistant Staphylococcus aureus (MRSA). In mice co-infected with influenza virus and MRSA and rece...